Lenacapavir: a giant step forward in HIV prevention-but a missed opportunity for achieving equity and access

BMJ. 2024 Oct 14:387:q2254. doi: 10.1136/bmj.q2254.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Anti-HIV Agents / therapeutic use
  • HIV Infections* / drug therapy
  • HIV Infections* / prevention & control
  • Health Equity
  • Health Services Accessibility*
  • Humans
  • Pre-Exposure Prophylaxis
  • Quinolones / therapeutic use

Substances

  • Quinolones
  • Anti-HIV Agents